SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-048135
Filing Date
2024-02-27
Accepted
2024-02-27 17:28:37
Documents
11
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-3ASR d769699ds3asr.htm S-3ASR 490936
2 EX-4.6 d769699dex46.htm EX-4.6 281430
3 EX-4.8 d769699dex48.htm EX-4.8 95451
4 EX-4.9 d769699dex49.htm EX-4.9 95243
5 EX-4.10 d769699dex410.htm EX-4.10 86566
6 EX-5.1 d769699dex51.htm EX-5.1 29168
7 EX-23.1 d769699dex231.htm EX-23.1 2418
8 EX-FILING FEES d769699dexfilingfees.htm EX-FILING FEES 66035
9 GRAPHIC g769699g0227044233568.jpg GRAPHIC 2534
10 GRAPHIC g769699g10a10.jpg GRAPHIC 197007
11 GRAPHIC g769699g52m47.jpg GRAPHIC 598628
  Complete submission text file 0001193125-24-048135.txt   2234526
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277424 | Film No.: 24688741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)